09/04/2019
Royal College of Surgeons in Ireland (RCSI) and Trinity College Dublin announced yesterday it has partnered with MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, to host the Dublin Pitch Event, the European qualifying round of the organization’s Showcase and Accelerator programme.
Each year, MedTech Innovator selects the industry’s most promising medical technology startups and emerging growth companies, matching them with healthcare leaders for mentorship and support. In 2019, MedTech Innovator will select 50 startups for participation in its programme and will award more than $500,000 in cash and in-kind prizes during its competition.
The event will take place at RCSI and will feature pitches from the best-in-class medical device, diagnostic, and digital health companies in Europe. Only the top applicants for MedTech Innovator’s 2019 programme are invited to present at the accelerator’s regional pitch events occurring across the United States and internationally.
In addition to pitching to a panel of judges, attendees will have the opportunity to network with MedTech Innovator partners, including investors, providers, and key industry executives. This event is one of a number of outreach activities under the Trinity -RCSI Knowledge Transfer Consortium – an initiative supported by Knowledge Transfer Ireland and Enterprise Ireland under the Technology Transfer Strengthening Initiative Phase 3 (TTSI3).
The programme will culminate on Sept. 23-25 in Boston, where all 50 companies will present at The MedTech Conference, powered by AdvaMed.
Programme acceptance is highly competitive and applications are reviewed by more than 150 executives and professionals from dozens of leading companies, including manufacturers, providers, and investors such as Johnson & Johnson, RCT Ventures, Baxter, BTG, HOYA Corp, NIPRO Medical Corp., Olympus Medical Systems Group, W.L Gore & Associates, Inc., and many more.
Speaking this week, RCSI’s Director of Research, Prof. Ray Stallings said, "RCSI aims to improve human health through innovative translational medical research. We are delighted to be partnering with MedTech Innovator and Trinity to host this event in order to foster innovation, improve healthcare and patient lives. We are looking forward to learning about the groundbreaking innovations that are being developed by the industry’s best and brightest entrepreneurs. This partnership with MedTech Innovator plays a vital role in advancing innovation in Dublin, Ireland and furthering the medtech ecosystem as a whole, and we are proud to be working together to achieve better patient outcomes and provide value to the healthcare system."
Head of Trinity’s Office of Corporate Partnership and Knowledge Exchange, Dr. Declan Weldon added, "Trinity is Ireland’s leading University and has a successful track-record in world-class research generating world-class spin-outs in all sectors and particularly in MedTech, Life Sciences, ICT and Materials. We wish all participants the best in the MedTech innovator programme, including Trinity campus company prospects Starling Surgical and Head Diagnostics."
www.businessworld.ie